16. Jang HC,Kim SH,Kim KH,et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem[J]. Clin Infect Dis,2009,49(3):395-401. 17. Thirot H, Briquet C, Frippiat F, et al. Clinical Use and Adverse Drug ...
MRSA 与CA-MRSA的区别 Multidrug resistant (MDR), including: Clindamycin Gentamicin Fluoroquinolone SCCmec type 1-3 Usually PVL negative Associated with nosocomial pneumonia (NP) and skin, surgical site, and bloodstream infections Mortality:28%-56% Can typically be treated with common oral antibiotics....
15. Gudiol C,Cuervo G,Shaw E,et al. Pharmaco therapeutic options for treating Staphylococcus aureus bacteremia[J]. Expert Opin Pharmacother,2017,18(18):1947-1963. 16. Jang HC,Kim SH,Kim KH,et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy ...
MRSA can also develop resistance to families of antibiotics other than the penicillins. In one reported case, oral rifampicin not only failed to eradicate the organism in four patients who were carrying it but also produced isolates that were highly resistant to the drug [11]. ...
In MRSA bacteremia, Abramson observed a 2.8-fold greater direct hospital cost of managing the patient (from $9661 for MSSA infections to $27,083 for MRSA infections). Greater cost is also observed for managing SSIs.1-3 MortalityIncreased mortality within 90 days following surgery is higher for...
Use of antistaphylococcal β-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding Clinical Infectious Diseases, 53 (2011), pp. 158-163 Google Scholar [67] J.A. Crompton, D.S. North, M....
46.Charles PG,Ward PB,Johnson PD,et al.Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.Clin Infect Dis,2004,38:448-451. 47.Wunderink RG,Niederman MS,Kollef MH,et al.Linezolid in methicillin-resistant staphylococcus aureus nosocomial pneumon...
Mina, P. et al. Risk of or Death from MRSA Bacteremia.Emerging Infectious Diseases. 7, 1072–1078 (2012). Google Scholar Nakamura, A. et al. Association between antimicrobial consumption and clinical isolates of methicillin-resistant Staphylococcus aureus: a 14-year study. J Infect Chemother. ...
Here we describe a case of limited form of GP diagnosed after presenting with MRSA bacteremia and pneumonia.CASE PRESENTATION: A 47 year-old-man presented with fever, respiratory distress and skin rash. He had recently received trimethoprim-sulphamethoxazole for a skin infection. Examination ...
Adults with Bacteremia or Infective Endocarditis, Native Valve1 Recommended duration of therapy Uncomplicated bacteremia – at least 2 weeks Complicated bacteremia – 4-6 weeks Infective endocarditis, native valve – 6 weeks Summary of Antibiotic Options for Adults with MRSA Bacteremia or Infective En...